{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T23:12:00Z","timestamp":1783120320753,"version":"3.54.6"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T00:00:00Z","timestamp":1765670400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100020784","name":"Gannan Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020784","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82460498"],"award-info":[{"award-number":["82460498"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.tranon.2025.102648","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T06:25:01Z","timestamp":1766125501000},"page":"102648","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Evaluation of the anti-tumor efficacy of prodigiosin in papillary thyroid cancer cell and animal models"],"prefix":"10.1016","volume":"64","author":[{"given":"Meiyu","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junwei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengqiao","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoni","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihang","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zanbing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2817-3125","authenticated-orcid":false,"given":"feijie","family":"wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haidong","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangtai","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.tranon.2025.102648_bib0001","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1002\/cam4.3823","article-title":"Global, regional, and national burden and quality of care index (QCI) of thyroid cancer: a systematic analysis of the global burden of disease study 1990-2017","volume":"10","author":"Azadnajafabad","year":"2021","journal-title":"Cancer Med."},{"issue":"10387","key":"10.1016\/j.tranon.2025.102648_bib0002","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/S0140-6736(23)00020-X","article-title":"Thyroid cancer","volume":"401","author":"Chen","year":"2023","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.tranon.2025.102648_bib0003","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1093\/annonc\/mdz400","article-title":"Thyroid cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"30","author":"Filetti","year":"2019","journal-title":"Ann. Oncol."},{"issue":"6","key":"10.1016\/j.tranon.2025.102648_bib0004","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1210\/er.2019-00085","article-title":"Contemporary debates in adult papillary thyroid cancer management","volume":"40","author":"McLeod","year":"2019","journal-title":"Endocr. Rev."},{"issue":"1","key":"10.1016\/j.tranon.2025.102648_bib0005","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/s41420-024-02157-2","article-title":"High aggressiveness of papillary thyroid cancer: from clinical evidence to regulatory cellular networks","volume":"10","author":"Zhang","year":"2024","journal-title":"Cell Death. Discov."},{"key":"10.1016\/j.tranon.2025.102648_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.100939","article-title":"Radioiodine therapy in advanced differentiated thyroid cancer: resistance and overcoming strategy","volume":"68","author":"Liu","year":"2023","journal-title":"Drug Resist. Updat."},{"issue":"7","key":"10.1016\/j.tranon.2025.102648_bib0007","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1158\/1078-0432.CCR-23-3503","article-title":"A new twist on a classic: enhancing radioiodine uptake in advanced thyroid cancer","volume":"30","author":"Lechner","year":"2024","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.tranon.2025.102648_bib0008","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.drudis.2020.03.017","article-title":"The production and bioactivity of prodigiosin: quo vadis?","volume":"25","author":"Lin","year":"2020","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.tranon.2025.102648_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2022.105449","article-title":"Antibacterial, antibiofilm and cytotoxic properties of prodigiosin produced by a newly isolated Serratia sp. C6LB from a milk collection center","volume":"164","author":"Jardak","year":"2022","journal-title":"Microb. Pathog."},{"issue":"21","key":"10.1016\/j.tranon.2025.102648_bib0010","doi-asserted-by":"crossref","first-page":"19755","DOI":"10.1021\/acs.jmedchem.4c02093","article-title":"Optimization of B-ring-functionalized antimalarial tambjamines and prodiginines","volume":"67","author":"Kumar","year":"2024","journal-title":"J. Med. Chem."},{"issue":"18","key":"10.1016\/j.tranon.2025.102648_bib0011","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27186030","article-title":"Extraction of the anticancer and antimicrobial agent, Prodigiosin, from Vibrio gazogenes PB1 and its identification by 1D and 2D NMR","volume":"27","author":"Vijay","year":"2022","journal-title":"Molecules."},{"key":"10.1016\/j.tranon.2025.102648_bib0012","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.977337","article-title":"Improving prodigiosin production by transcription factor engineering and promoter engineering in Serratia marcescens","volume":"13","author":"Pan","year":"2022","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.tranon.2025.102648_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173465","article-title":"Survivin modulation in the antimelanoma activity of prodiginines","volume":"888","author":"Branco","year":"2020","journal-title":"Eur. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.tranon.2025.102648_bib0014","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1158\/0008-5472.CAN-14-2430","article-title":"Small-molecule prodigiosin restores p53 tumor suppressor activity in chemoresistant colorectal cancer stem cells via c-Jun-mediated \u0394Np73 inhibition and p73 activation","volume":"76","author":"Prabhu","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.tranon.2025.102648_bib0015","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jare.2023.12.015","article-title":"Development of a bacterial gene transcription activating strategy based on transcriptional activator positive feedback","volume":"66","author":"Yu","year":"2024","journal-title":"J. Adv. Res."},{"issue":"12","key":"10.1016\/j.tranon.2025.102648_bib0016","doi-asserted-by":"crossref","first-page":"7236","DOI":"10.1007\/s12010-023-04426-9","article-title":"Identification of novel protein targets of prodigiosin for breast cancer using inverse virtual screening methods","volume":"195","author":"Paul","year":"2023","journal-title":"Appl. Biochem. Biotechnol."},{"issue":"1","key":"10.1016\/j.tranon.2025.102648_bib0017","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15010097","article-title":"Antimetastatic properties of prodigiosin and the BH3-Mimetic obatoclax (GX15-070) in Melanoma","volume":"15","author":"Espona-Fiedler","year":"2022","journal-title":"Pharmaceutics."},{"issue":"46","key":"10.1016\/j.tranon.2025.102648_bib0018","doi-asserted-by":"crossref","first-page":"13150","DOI":"10.1073\/pnas.1616336113","article-title":"Prodigiosin inhibits wnt\/\u03b2-catenin signaling and exerts anticancer activity in breast cancer cells","volume":"113","author":"Wang","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U S. A"},{"key":"10.1016\/j.tranon.2025.102648_bib0019","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.tiv.2019.05.003","article-title":"Prodigiosin induces apoptosis and inhibits autophagy via the extracellular signal-regulated kinase pathway in K562 cells","volume":"60","author":"Ji","year":"2019","journal-title":"Toxicol. In. Vitro"},{"issue":"7","key":"10.1016\/j.tranon.2025.102648_bib0020","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1111\/j.1476-5381.2012.01921.x","article-title":"Prodigiosin down-regulates SKP2 to induce p27(KIP1) stabilization and antiproliferation in human lung adenocarcinoma cells","volume":"166","author":"Hsieh","year":"2012","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.tranon.2025.102648_bib0021","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.3390\/cimb46030116","article-title":"Induction of endoplasmic reticulum stress by prodigiosin in yeast saccharomyces cerevisiae","volume":"46","author":"Nguyen","year":"2024","journal-title":"Curr. Issues. Mol. Biol."},{"key":"10.1016\/j.tranon.2025.102648_bib0022","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.728381","article-title":"p53 Activation effect in the balance of T regulatory and effector cell subsets in patients with thyroid cancer and autoimmunity","volume":"12","author":"Arena","year":"2021","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.tranon.2025.102648_bib0023","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.7150\/thno.66142","article-title":"KDM1A promotes thyroid cancer progression and maintains stemness through the wnt\/\u03b2-catenin signaling pathway","volume":"12","author":"Zhang","year":"2022","journal-title":"Theranostics."},{"issue":"9","key":"10.1016\/j.tranon.2025.102648_bib0024","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/s41419-020-02827-w","article-title":"Exosomal lncRNA DOCK9-AS2 derived from cancer stem cell-like cells activated wnt\/\u03b2-catenin pathway to aggravate stemness, proliferation, migration, and invasion in papillary thyroid carcinoma","volume":"11","author":"Dai","year":"2020","journal-title":"Cell Death. Dis."},{"issue":"8","key":"10.1016\/j.tranon.2025.102648_bib0025","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1038\/s41379-018-0070-2","article-title":"Cribriform-morular variant of thyroid carcinoma: a neoplasm with distinctive phenotype associated with the activation of the WNT\/\u03b2-catenin pathway","volume":"31","author":"Cameselle-Teijeiro","year":"2018","journal-title":"Mod. Pathol."},{"issue":"11","key":"10.1016\/j.tranon.2025.102648_bib0026","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/s41419-024-07164-w","article-title":"FATS inhibits the wnt pathway and induces apoptosis through degradation of MYH9 and enhances sensitivity to paclitaxel in breast cancer","volume":"15","author":"Song","year":"2024","journal-title":"Cell Death. Dis."},{"issue":"6","key":"10.1016\/j.tranon.2025.102648_bib0027","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1053\/j.gastro.2023.01.041","article-title":"N6-Methyladenosine-mediated up-regulation of FZD10 regulates liver cancer stem cells' Properties and lenvatinib resistance through WNT\/\u03b2-catenin and hippo signaling pathways","volume":"164","author":"Wang","year":"2023","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.tranon.2025.102648_bib0028","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ydbio.2017.01.003","article-title":"The thyroid hormone nuclear receptors and the wnt\/\u03b2-catenin pathway: an intriguing liaison","volume":"422","author":"Skah","year":"2017","journal-title":"Dev. Biol."},{"issue":"1","key":"10.1016\/j.tranon.2025.102648_bib0029","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12935-025-03644-x","article-title":"Overexpressed NEK2 contributes to progression and cisplatin resistance through activating the wnt\/\u03b2-catenin signaling pathway in cervical cancer","volume":"25","author":"Haiye","year":"2025","journal-title":"Cancer Cell Int."},{"issue":"1","key":"10.1016\/j.tranon.2025.102648_bib0030","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41392-024-01851-y","article-title":"Cancer stem cells: advances in knowledge and implications for cancer therapy","volume":"9","author":"Chu","year":"2024","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.tranon.2025.102648_bib0031","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/s41392-024-01885-2","article-title":"Mechanism insights and therapeutic intervention of tumor metastasis: latest developments and perspectives","volume":"9","author":"Shi","year":"2024","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.tranon.2025.102648_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117925","article-title":"Zoledronic acid inhibits thyroid cancer stemness and metastasis by repressing M2-like tumor-associated macrophages induced wnt\/\u03b2-catenin pathway","volume":"256","author":"Lv","year":"2020","journal-title":"Life Sci."},{"issue":"7","key":"10.1016\/j.tranon.2025.102648_bib0033","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1245\/s10434-016-5185-4","article-title":"Epigenetic alterations and canonical pathway disruption in papillary thyroid cancer: a genome-wide methylation analysis","volume":"23","author":"White","year":"2016","journal-title":"Ann. Surg. Oncol."},{"issue":"1","key":"10.1016\/j.tranon.2025.102648_bib0034","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41568-020-00307-z","article-title":"Mutations and mechanisms of WNT pathway tumour suppressors in cancer","volume":"21","author":"Bugter","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.tranon.2025.102648_bib0035","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1171816","article-title":"\u03b2-catenin attenuation leads to up-regulation of activating NKG2D ligands and tumor regression in Braf(V600E)-driven thyroid cancer cells","volume":"14","author":"Zou","year":"2023","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.tranon.2025.102648_bib0036","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s12943-022-01638-1","article-title":"Hypoxia-induced lncRNA STEAP3-AS1 activates wnt\/\u03b2-catenin signaling to promote colorectal cancer progression by preventing m(6)A-mediated degradation of STEAP3 mRNA","volume":"21","author":"Zhou","year":"2022","journal-title":"Mol. Cancer"},{"issue":"4","key":"10.1016\/j.tranon.2025.102648_bib0037","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/s41419-021-03641-8","article-title":"LDHA induces EMT gene transcription and regulates autophagy to promote the metastasis and tumorigenesis of papillary thyroid carcinoma","volume":"12","author":"Hou","year":"2021","journal-title":"Cell Death. Dis."},{"issue":"3","key":"10.1016\/j.tranon.2025.102648_bib0038","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41388-023-02889-y","article-title":"Dual targeting of MAPK and PI3K pathways unlocks redifferentiation of Braf-mutated thyroid cancer organoids","volume":"43","author":"Lasolle","year":"2024","journal-title":"Oncogene"},{"issue":"31","key":"10.1016\/j.tranon.2025.102648_bib0039","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abf3657","article-title":"Characterizing dedifferentiation of thyroid cancer by integrated analysis","volume":"7","author":"Luo","year":"2021","journal-title":"Sci. Adv."},{"issue":"13","key":"10.1016\/j.tranon.2025.102648_bib0040","doi-asserted-by":"crossref","first-page":"6251","DOI":"10.7150\/thno.57689","article-title":"Molecular mechanisms of radioactive iodine refractoriness in differentiated thyroid cancer: impaired sodium iodide symporter (NIS) expression owing to altered signaling pathway activity and intracellular localization of NIS","volume":"11","author":"Oh","year":"2021","journal-title":"Theranostics."}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523325003791?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523325003791?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T11:54:58Z","timestamp":1781178898000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523325003791"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":40,"alternative-id":["S1936523325003791"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2025.102648","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of the anti-tumor efficacy of prodigiosin in papillary thyroid cancer cell and animal models","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2025.102648","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102648"}}